STOCK OPTIONS (Details 4) - $ / shares |
6 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
|
Exercisable, Number of Options | 837,793 | 831,138 | 815,351 | 831,138 |
Warrants Exercisable [Member] | ||||
Weighted average remaining life in years | 2 years 10 months 24 days | |||
Exercisable, Number of Options | 333,855 | |||
Exercise price | $ 5.06 | |||
Warrants Exercisable [Member] | 5.06 [Member] | ||||
Weighted average remaining life in years | 2 years 10 months 24 days | |||
Exercisable, Number of Options | 333,855 | |||
Exercise price | $ 5.06 | |||
Warrants Outstanding [Member] | ||||
Weighted average remaining life in years | 2 years 10 months 24 days | |||
Exercise price | $ 5.06 | |||
Number of outstanding | 333,855 | |||
Warrants Outstanding [Member] | 5.06 [Member] | ||||
Weighted average remaining life in years | 2 years 10 months 24 days | |||
Exercise price | $ 5.06 | |||
Number of outstanding | 333,855 |
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|